Vírus do Nilo Ocidental

Referências

Principais artigos

Hayes EB, Sejvar JJ, Zaki SR, et al. Virology, pathology, and clinical manifestations of West Nile virus disease. Emerg Infect Dis. 2005;11:1174-1179. Resumo

Centers for Disease Control and Prevention. West Nile virus in the United States: guidelines for surveillance, prevention, and control. June 2013 [internet publication].Texto completo

Centers for Disease Control and Prevention. West Nile virus disease therapeutics: review of the literature for healthcare providers. February 2018 [internet publication].Texto completo

Artigos de referência

1. Mostashari F, Bunning ML, Kitsutani PT, et al. Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey. Lancet. 2001;358:261-264. Resumo

2. Pridjian G, Sirois PA, McRae S, et al. Prospective study of pregnancy and newborn outcomes in mothers with West nile illness during pregnancy. Birth Defects Res A Clin Mol Teratol. 2016;106:716-723.Texto completo  Resumo

3. Campbell GL, Marfin AA, Lanciotti RS, et al. West Nile virus. Lancet Infect Dis. 2002;2:519-529. Resumo

4. Petersen LR, Marfin AA. West Nile virus: a primer for the clinician. Ann Intern Med. 2002;137:173-179.Texto completo  Resumo

5. Nash D, Mostashari F, Fine A, et al. The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med. 2001;344:1807-1814.Texto completo  Resumo

6. Centers for Disease Control and Prevention. Provisional surveillance summary of the West Nile virus epidemic - United States, January-November 2002. MMWR Morb Mortal Wkly Rep. 2002;51:1129-1133.Texto completo  Resumo

7. Centers for Disease Control and Prevention. Statistics and maps. June 2022 [internet publication].Texto completo

8. Centers for Disease Control and Prevention. West nile virus and other domestic nationally notifiable arboviral diseases- United States, 2020. May 2022 [internet publication].Texto completo  Resumo

9. McDonald E, Martin SW, Landry K, et al. West Nile virus and other domestic nationally notifiable arboviral diseases - United States, 2018. MMWR Morb Mortal Wkly Rep. 2019 Aug 9;68(31):673-678.Texto completo  Resumo

10. European Centre for Disease Prevention and Control. Epidemiological update: West Nile virus transmission season in Europe, 2018. December 2018 [internet publication].Texto completo

11. Public Health England. HAIRS risk assessment: West Nile virus. Dec 2020 [internet publication].Texto completo  Resumo

12. CDC: dynamic map of county arboviral case counts and incidence data Resumo

13. Hayes EB, Komar N, Nasci RS, et al. Epidemiology and transmission dynamics of West Nile virus disease. Emerg Infect Dis. 2005;11:1167-1173. Resumo

14. Beasley DW, Davis CT, Whiteman M, et al. Molecular determinants of virulence of West Nile virus in North America. Arch Virol Suppl. 2004;(18):35-41. Resumo

15. Groves JA, Shafi H, Nomura JH, et al. A probable case of West Nile virus transfusion transmission. Transfusion. 2017 Mar;57(3pt2):850-856. Resumo

16. Centers for Disease Control and Prevention. Laboratory-acquired West Nile virus infections - United States, 2002. MMWR Morb Mortal Wkly Rep. 2002;51:1133-1135.Texto completo  Resumo

17. Iwamoto M, Jernigan DB, Guasch A, et al. Transmission of West Nile virus from an organ donor to four transplant recipients. N Engl J Med. 2003;348:2196-2203.Texto completo  Resumo

18. Biggerstaff BJ, Petersen LR. Estimated risk of West Nile virus transmission through blood transfusion in the United States, 2002. Transfusion. 2003;43:1007-1017. Resumo

19. Centers for Disease Control and Prevention. Intrauterine West Nile virus infection - New York, 2002. MMWR Morb Mortal Wkly Rep. 2002;51:1135-1136.Texto completo  Resumo

20. Centers for Disease Control and Prevention. Possible West Nile virus transmission to an infant through breast-feeding - Michigan, 2002. MMWR Morb Mortal Wkly Rep. 2002;51:877-878.Texto completo  Resumo

21. Hayes EB, Sejvar JJ, Zaki SR, et al. Virology, pathology, and clinical manifestations of West Nile virus disease. Emerg Infect Dis. 2005;11:1174-1179. Resumo

22. Sampson BA, Ambrosi C, Charlot A, et al. The pathology of human West Nile Virus infection. Hum Pathol. 2000;31:527-531. Resumo

23. Shieh WJ, Guarner J, Layton M, et al. The role of pathology in an investigation of an outbreak of West Nile encephalitis in New York, 1999. Emerg Infect Dis. 2000;6:370-372.Texto completo  Resumo

24. Kumar D, Prasad GV, Zaltzman J, et al. Community-acquired West Nile virus infection in solid-organ transplant recipients. Transplantation. 2004;77:399-402. Resumo

25. Centers for Disease Control and Prevention (CDC). West Nile virus infections in organ transplant recipients - New York and Pennsylvania, August-September, 2005. MMWR Morb Mortal Wkly Rep. 2005;54:1021-1023.Texto completo  Resumo

26. Centers for Disease Control and Prevention. West Nile virus in the United States: guidelines for surveillance, prevention, and control. June 2013 [internet publication].Texto completo

27. Lee BY, Biggerstaff BJ. Screening the United States blood supply for West Nile Virus: a question of blood, dollars, and sense. PLoS Med. 2006;3:e99.Texto completo  Resumo

28. Korves CT, Goldie SJ, Murray MB. Cost-effectiveness of alternative blood-screening strategies for West Nile Virus in the United States. PLoS Med. 2006;3:e21.Texto completo  Resumo

29. Joint United Kingdom (UK) Blood Transfusion and Tissue Transplantation Services Professional Advisory Committee. JPAC Position Statement on West Nile Virus. August 2015 [internet publication].Texto completo

30. National Institutes of Health. NIH-funded vaccine for West Nile virus enters human clinical trials. July 2015 [internet publication].Texto completo

31. Pierce KK, Whitehead SS, Kirkpatrick BD, et al. A live attenuated chimeric West Nile virus vaccine, rWN/DEN4Δ30, is well tolerated and immunogenic in flavivirus-naive older adult volunteers. J Infect Dis. 2017 Jan 1;215(1):52-55.Texto completo  Resumo

32. Chan CK, Limstrom SA, Tarasewicz DG, et al. Ocular features of West Nile virus infection in North America: a study of 14 eyes. Ophthalmology. 2006;113:1539-1546. Resumo

33. Sejvar JJ, Bode AV, Marfin AA, et al. West Nile virus-associated flaccid paralysis. Emerg Infect Dis. 2005;11:1021-1027.Texto completo  Resumo

34. Miller JM, Binnicker MJ, Campbell S, et al. A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiology. Clin Infect Dis. 2018 Aug 31;67(6):e1-e94.Texto completo  Resumo

35. Marfin AA, Gubler DJ. West Nile encephalitis: an emerging disease in the United States. Clin Infect Dis. 2001;33:1713-1719. Resumo

36. Martin DA, Muth DA, Brown T, et al. Standardization of immunoglobulin M capture enzyme-linked immunosorbent assays for routine diagnosis of arboviral infections. J Clin Microbiol. 2000;38:1823-1826.Texto completo  Resumo

37. Roehrig JT, Nash D, Maldin B, et al. Persistence of virus-reactive serum immunoglobulin M antibody in confirmed West Nile virus encephalitis cases. Emerg Infect Dis. 2003;9:376-379.Texto completo  Resumo

38. Kapoor H, Signs K, Somsel P, et al. Persistence of West Nile Virus (WNV) IgM antibodies in cerebrospinal fluid from patients with CNS disease. J Clin Virol. 2004;31:289-291. Resumo

39. Lustig Y, Mannasse B, Koren R, et al. Superiority of West Nile virus RNA detection in whole blood for diagnosis of acute infection. J Clin Microbiol. 2016;54:2294-2297.Texto completo  Resumo

40. Lanciotti RS, Kerst AJ, Nasci RS, et al. Rapid detection of West Nile virus from human clinical specimens, field-collected mosquitoes, and avian samples by a TaqMan reverse transcriptase-PCR assay. J Clin Microbiol. 2000;38:4066-4071.Texto completo  Resumo

41. Sejvar JJ, Haddad MB, Tierney BC, et al. Neurologic manifestations and outcome of West Nile virus infection. JAMA. 2003;290:511-515. Erratum in: JAMA. 2003;290:1318.Texto completo  Resumo

42. Watson JT, Pertel PE, Jones RC, et al. Clinical characteristics and functional outcomes of West Nile Fever. Ann Intern Med. 2004;141:360-365. Resumo

43. Hayes EB, Gubler DJ. West Nile virus: epidemiology and clinical features of an emerging epidemic in the United States. Ann Rev Med. 2006;57:181-194. Resumo

44. Sejvar JJ, Leis AA, Stokic DS, et al. Acute flaccid paralysis and West Nile virus infection. Emerg Infect Dis. 2003;9:788-793.Texto completo  Resumo

45. Li J, Loeb JA, Shy ME, et al. Asymmetric flaccid paralysis: a neuromuscular presentation of West Nile virus infection. Ann Neurol. 2003;53:703-710. Resumo

46. Weiss D, Carr D, Kellachan J, et al. Clinical findings of West Nile virus infection in hospitalized patients, New York and New Jersey, 2000. Emerg Infect Dis. 2001 Jul-Aug;7(4):654-8.Texto completo  Resumo

47. Pepperell C, Rau N, Krajden S, et al. West Nile virus infection in 2002: morbidity and mortality among patients admitted to hospital in southcentral Ontario. CMAJ. 2003 May 27;168(11):1399-405.Texto completo  Resumo

48. Ferguson DD, Gershman K, LeBailly A, et al. Characteristics of the rash associated with West Nile virus fever. Clin Infect Dis. 2005;41:1204-1207. Resumo

49. Georges AJ, Lesbordes JL, Georges-Courbot MC, et al. Fatal hepatitis from West Nile virus. Ann Inst Pasteur Virol. 1987;138:237-244.

50. Perelman A, Stern J. Acute pancreatitis in West Nile fever. Am J Trop Med Hyg. 1974;23:1150-1152. Resumo

51. Carson PJ, Konewko P, Wold KS, et al. Long-term clinical and neuropsychological outcomes of West Nile virus infection. Clin Infect Dis. 2006;43:723-730. Resumo

52. Leis AA, Stokic DS. Neuromuscular manifestations of human West Nile virus infection. Curr Treat Options Neurol. 2005;7:15-22. Resumo

53. Jeha LE, Sila CA, Lederman RJ. West Nile virus infection: a new acute paralytic illness. Neurology. 2003;61:55-59. Resumo

54. Ahmed S, Libman R, Wesson K, et al. Guillain-Barre syndrome: an unusual presentation of West Nile virus infection. Neurology. 2000;55:144-146. Resumo

55. Rawal A, Gavin PJ, Sturgis CD. Cerebrospinal fluid cytology in seasonal epidemic West Nile virus meningo-encephalitis. Diagn Cytopathol. 2006;34:127-129. Resumo

56. Tyler KL, Pape J, Goody RJ, et al. CSF findings in 250 patients with serologically confirmed West Nile virus meningitis and encephalitis. Neurology. 2006;66:361-365. Resumo

57. Aksamit AJ. Herpes simplex encephalitis in adults and older children. Curr Treat Options Neurol. 2005;7:145-150. Resumo

58. Cinque P, Cleator GM, Weber T, et al. The role of laboratory investigation in the diagnosis and management of patients with suspected herpes simplex encephalitis: a consensus report. The EU Concerted Action on Virus Meningitis and Encephalitis. J Neurol Neurosurg Psychiatry. 1996;61:339-345.Texto completo  Resumo

59. Luby JP. Infections of the central nervous system. Am J Med Sci. 1992;304:379-391. Resumo

60. Tsai TF. Arboviral infections in the United States. Infect Dis Clin North Am. 1991;5:73-102. Resumo

61. Fitch MT, van de Beek D. Emergency diagnosis and treatment of adult meningitis. Lancet Infect Dis. 2007;7:191-200. Resumo

62. Bicanic T, Harrison TS. Cryptococcal meningitis. Br Med Bull. 2005 Apr 18;72:99-118.Texto completo  Resumo

63. Bhigjee AI, Padayachee R, Paruk H, et al. Diagnosis of tuberculous meningitis: clinical and laboratory parameters. Int J Infect Dis. 2007;11:348-354. Resumo

64. Sejvar JJ, Marfin AA. Manifestations of West Nile neuroinvasive disease. Rev Med Virol. 2006;16:209-224. Resumo

65. Wilske B, Fingerle V, Schulte-Spechtel U. Microbiological and serological diagnosis of Lyme borreliosis. FEMS Immunol Med Microbiol. 2007;49:13-21. Resumo

66. Pachner AR, Steiner I. Lyme neuroborreliosis: infection, immunity, and inflammation. Lancet Neurol. 2007;6:544-552. Resumo

67. Helmick CG, Bernard KW, D'Angelo LJ. Rocky Mountain spotted fever: clinical, laboratory, and epidemiological features of 262 cases. J Infect Dis. 1984;150:480-488. Resumo

68. Centers for Disease Control and Prevention. Diagnosis and management of tickborne rickettsial diseases: Rocky mountain spotted fever and other spotted fever group rickettsioses, ehrlichioses, and anaplasmosis — United States. June 2017 [internet publication].Texto completo  Resumo

69. Cunha BA. The atypical pneumonias: clinical diagnosis and importance. Clin Microbiol Infect. 2006 May;12 Suppl 3:12-24. Resumo

70. Tatter SB. Neurosurgical management of brain tumors. Neuroimaging Clin N Am. 1999;9:779-799. Resumo

71. Kastrup O, Wanke I, Maschke M. Neuroimaging of infections. NeuroRx. 2005;2:324-332.Texto completo  Resumo

72. Castillo PR, Miller DA, Meschia JF. Choice of neuroimaging in perioperative acute stroke management. Neurol Clin. 2006;24:807-820. Resumo

73. Centers for Disease Control and Prevention. Arboviral diseases, neuroinvasive and non-neuroinvasive 2015 case definition. 2015 [internet publication].Texto completo

74. Hayes EB. West Nile virus disease in children. Pediatric Infect Dis J. 2006;25:1065-1066. Resumo

75. Rimon A, Straussberg R, Amir J. West Nile encephalitis mimicking herpes encephalitis. Pediatr Neurol. 2006;35:62-64. Resumo

76. Centers for Disease Control and Prevention. West Nile virus disease therapeutics: review of the literature for healthcare providers. February 2018 [internet publication].Texto completo

77. Chowers MY, Lang R, Nassar F, et al. Clinical characteristics of the West Nile fever outbreak, Israel, 2000. Emerg Infect Dis. 2001;7:675-678. Resumo

78. Pepperell C, Rau N, Krajden S, et al. West Nile virus infection in 2002: morbidity and mortality among patients admitted to hospital in southcentral Ontario. CMAJ. 2003;168:1399-1405.Texto completo  Resumo

79. Hart J Jr, Tillman G, Kraut MA, et al. West Nile virus neuroinvasive disease: neurological manifestations and prospective longitudinal outcomes. BMC Infect Dis. 2014 May 9;14:248.Texto completo  Resumo

80. Petersen LR, Marfin AA, Gubler DJ. West Nile virus. JAMA. 2003;290:524-528. Resumo

81. Gelfand MS. West Nile virus infection. What you need to know about this emerging threat. Postgrad Med. 2003;114:31-38. Resumo

82. Bosanko CM, Gilroy J, Wang AM, et al. West Nile virus encephalitis involving the substantia nigra: neuroimaging and pathologic findings with literature review. Arch Neurol. 2003;60:1448-1452.Texto completo  Resumo

83. Johnson RT, Cornblath DR. Poliomyelitis and flaviviruses. Ann Neurol. 2003;53:691-692. Resumo

84. Zaltzman R, Klein C, Gordon CR. Opsoclonus myoclonus ataxia associated with West Nile virus infection: A dramatic presentation with benign prognosis? J Neurol Sci. 2017;376:38-41. Resumo

85. Samaan Z, McDermid Vaz S, et al. Neuropsychological Impact of West Nile virus infection: an extensive neuropsychiatric assessment of 49 cases in Canada. PLoS One. 2016;11:e0158364.Texto completo  Resumo

O uso deste conteúdo está sujeito ao nosso aviso legal